Expression of this Mcl1 variant may therefore represent an adaption of tumor cells to avoid extrinsic death signaling and may thereby serve as a diagnostic and/or therapeutic gene in neuroblastoma and other malignancies. This evidence concerns the gene MCL1 and neuroblastoma.